Li, Zexu http://orcid.org/0000-0002-4685-4656
Li, Zihan http://orcid.org/0000-0001-5082-9560
Cheng, Xiaolong
Wang, Shengnan
Wang, Xiaofeng
Ma, Shixin
Lu, Zhiyan
Zhang, Han
Zhao, Wenchang
Chen, Zhisong
Yao, Yingjia
Zhang, Cheng
Chao, Lumen
Li, Wei http://orcid.org/0000-0002-2163-7903
Fei, Teng http://orcid.org/0000-0001-9620-0450
Article History
Received: 4 August 2022
Accepted: 20 September 2023
First Online: 23 October 2023
Competing interests
: W.L. is a paid consultant to Tavros Therapeutics, Inc. All other authors declare no competing interests.